Literature DB >> 16306429

Vascular function and mild renal impairment in stable coronary artery disease.

Pim van der Harst1, Tom D J Smilde, Hendrik Buikema, Adriaan A Voors, Gerjan Navis, Dirk J van Veldhuisen, Wiek H van Gilst.   

Abstract

OBJECTIVE: In patients with coronary artery disease, the concomitant presence of renal function impairment is associated with decreased survival. We aimed to assess whether in coronary artery diseased patients renal function impairment is associated with systemic vascular function, functional parameters of the renin-angiotensin system, or inflammation as potential mediators for cardiovascular risk. METHODS AND
RESULTS: We studied 125 patients, 87% male, with a mean age of 62.2+/-8.2 years; 72% had 3-vessel disease, and mean renal function was 74+/-13 mL/min per 1.73 m2. Internal thoracic artery rings were sampled during coronary bypass surgery and used for in vitro vascular measurements. We could not establish an association between endothelium-dependent vasorelaxation (response to methacholine) and renal function. In addition, vascular response to potassium chloride, phenylephrine, and angiotensin II were not associated with renal function. Finally, serum angiotensin-converting enzyme (ACE) activity, usage of ACE inhibitors, C-reactive protein, and soluble intercellular adhesion molecule 1 were not related to renal function.
CONCLUSIONS: In coronary artery disease patients, mild renal function impairment is not associated with systemic vasomotor responsiveness, inflammation, or functional systemic parameters of the renin-angiotensin system. The relation between systemic endothelial dysfunction and mild renal insufficiency might be more complicated than previously thought.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306429     DOI: 10.1161/01.ATV.0000197844.06411.22

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  4 in total

1.  Responsiveness of internal thoracic arteries to nitroglycerin in patients with renal failure.

Authors:  Masashi Tawa; Takeshi Kinoshita; Tohru Asai; Tomoaki Suzuki; Takaharu Ishibashi; Tomio Okamura
Journal:  Heart Vessels       Date:  2017-12-11       Impact factor: 2.037

2.  Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.

Authors:  Tom D J Smilde; Kevin Damman; Pim van der Harst; Gerjan Navis; B Daan Westenbrink; Adriaan A Voors; Frans Boomsma; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Clin Res Cardiol       Date:  2008-10-31       Impact factor: 5.460

Review 3.  Aging, telomeres and heart failure.

Authors:  Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Jardi Huzen; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

Review 4.  Endothelial dysfunction as a target for prevention of cardiovascular disease.

Authors:  Daniele Versari; Elena Daghini; Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.